Henry F. McFarland, MD
Affiliations: | NINDS / Neuroimmunology Branch | National Institutes of Health, Bethesda, MD |
Area:
multiple sclerosis, neuroimmunology,MR imagingGoogle:
"Henry McFarland"Mean distance: 20.48 (cluster 46)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Suto DJ, Nair G, Sudarshana DM, et al. (2020) Manganese-Enhanced MRI in Patients with Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. 41: 1569-1576 |
Neil S, Huh J, Baronas V, et al. (2017) Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models. Brain, Behavior, and Immunity |
Sati P, Oh J, Constable RT, et al. (2016) The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nature Reviews. Neurology |
Stone LA, Cutter GR, Fisher E, et al. (2015) Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging |
Borges IT, Shea CD, Ohayon J, et al. (2013) The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 2: 133-140 |
Yuen TJ, Johnson KR, Miron VE, et al. (2013) Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination. Brain : a Journal of Neurology. 136: 1035-47 |
Ohayon J, Oh U, Richert N, et al. (2013) CNS vasculitis in a patient with MS on daclizumab monotherapy. Neurology. 80: 453-7 |
Quandt JA, Huh J, Baig M, et al. (2012) Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 189: 2897-908 |
Bielekova B, Richert N, Herman ML, et al. (2011) Intrathecal effects of daclizumab treatment of multiple sclerosis Neurology. 77: 1877-1886 |
McFarland H. (2011) The importance of clinical trials in unraveling the mysteries of multiple sclerosis Journal of Neuroimmunology. 231: 3-6 |